Earlier menarche is associated with fatty liver and abdominal ectopic fat in midlife, independent of young adult BMI: The CARDIA study

Obesity

Volumn 23, Issue 2, 2015, Pages 468-474

  Mueller, Noel T ^a,b,c   Pereira, Mark A ^c   Demerath, Ellen W ^c   Dreyfus, Jill G ^c   MacLehose, Richard F ^c   Carr, J Jeffrey ^d   Terry, James G ^d   Jacobs, David R ^c  

^a Columbia University Medical Center ^*  (United States)

^b University of Minnesota ^*  (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADIPOSE TISSUE; ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BODY MASS; CAUCASIAN; COMPUTED TOMOGRAPHY SCANNER; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMUSCULAR ADIPOSE TISSUE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MENARCHE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONALCOHOLIC FATTY LIVER; SUBCUTANEOUS FAT; WEIGHT GAIN; YOUNG ADULT; ABDOMINAL FAT; ADOLESCENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FATTY LIVER; METABOLISM; MULTICENTER STUDY; OBESITY; RADIOGRAPHY;

ABDOMINAL FAT; ADIPOSITY; ADOLESCENT; ADULT; BODY MASS INDEX; FATTY LIVER; FEMALE; HUMANS; MENARCHE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84922753028     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20950     Document Type: Article

References (35)

1. Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9 (6): 524-530.
2. Targher G, Byrne CD,. Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab 2013; 98 (2): 483-495.
3. Karapanou O, Papadimitriou A,. Determinants of menarche. Reprod Biol Endocrinol 2010; 8: 115.
4. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS,. The relation of menarcheal age to obesity in childhood and adulthood: the Bogalusa heart study. BMC pediatrics 2003; 3: 3.
5. Feng Y, Hong X, Wilker E, et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008; 196 (2): 590-597.
6. Stockl D, Meisinger C, Peters A, et al. Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 study. PloS one 2011; 6 (10): e26076.
7. Glueck CJ, Morrison JA, Wang P, Woo JG,. Early and late menarche are associated with oligomenorrhea and predict metabolic syndrome 26years later. Metab Clin Exp 2013; 62 (11): 1597-1606.
8. Mueller NT, Odegaard AO, Gross MD, Koh WP, Yuan JM, Pereira MA,. Age at menarche and cardiovascular disease mortality in Singaporean Chinese women: the Singapore Chinese Health Study. Ann Epidemiol 2012; 22 (10): 717-722.
9. Dreyfus JG, Lutsey PL, Huxley R, et al. Age at menarche and risk of type 2 diabetes among African-American and white women in the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2012; 55 (9): 2371-2380.
10. He C, Zhang C, Hunter DJ, et al. Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol 2010; 171 (3): 334-344.
11. Pierce MB, Kuh D, Hardy R,. The role of BMI across the life course in the relationship between age at menarche and diabetes, in a British Birth Cohort. Diabet Med 2012; 29 (5): 600-603.
12. Mueller NT, Duncan BB, Barreto SM, et al. Earlier age at menarche is associated with higher diabetes risk and cardiometabolic disease risk factors in Brazilian adults: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Cardiovasc Diabetol 2014; 13 (1): 22.
13. Trikudanathan S, Pedley A, Massaro JM, et al. Association of female reproductive factors with body composition: the framingham heart study. J Clin Endocrinol Metab 2013; 98 (1): 236-244.
14. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988; 41 (11): 1105-1116.
15. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 2012; 107 (6): 811-826.
16. Sijtsma FP, Meyer KA, Steffen LM, et al. Longitudinal trends in diet and effects of sex, race, and education on dietary quality score change: the Coronary Artery Risk Development in Young Adults study. Am J Clin Nutr 2012; 95 (3): 580-586.
17. Davidson LE, Kuk JL, Church TS, Ross R,. Protocol for measurement of liver fat by computed tomography. J Appl Physiol (Bethesda, Md: 1985) 2006; 100 (3): 864-868.
18. Liu J, Musani SK, Bidulescu A, et al. Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study. Atherosclerosis 2012; 224 (2): 521-525.
19. Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007; 188 (5): 1307-1312.
20. Zeb I, Li D, Nasir K, Katz R, Larijani VN, Budoff MJ,. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol 2012; 19 (7): 811-818.
21. Spiegelman D, Hertzmark E,. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005; 162 (3): 199-200.
22. Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F,. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. J Clin Endocrinol Metab 2011; 96 (8): E1262-E1267.
23. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G,. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53 (2): 372-384.
24. Yu MW, Chang HC, Chang SC, et al. Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk. Hepatology 2003; 38 (6): 1393-1400.
25. Kaplowitz PB,. Link between body fat and the timing of puberty. Pediatrics 2008; 121 Suppl 3: S208-S217.
26. Dunger DB, Ahmed ML, Ong KK,. Early and late weight gain and the timing of puberty. Mol Cell Endocrinol 2006; 254-255: 140-145.
27. Wilson ME, Fisher J, Chikazawa K, et al. Leptin administration increases nocturnal concentrations of luteinizing hormone and growth hormone in juvenile female rhesus monkeys. J Clin Endocrinol Metab 2003; 88 (10): 4874-4883.
28. Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Honjo H,. Leptin directly stimulates aromatase activity in human luteinized granulosa cells. Mol Human Reprod 1999; 5 (8): 708-713.
29. Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F,. Early metformin therapy to delay menarche and augment height in girls with precocious pubarche. Fertil Steril 2011; 95 (2): 727-730.
30. Ibanez L, Ong K, Valls C, Marcos MV, Dunger DB, de Zegher F,. Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 2006; 91 (8): 2888-2891.
31. Ibanez L, Valls C, Ong K, Dunger DB, de Zegher F,. Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty. J Clin Endocrinol Metab 2006; 91 (6): 2068-2073.
32. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC,. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999; 20 (4): 535-582.
33. Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER,. Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Clin Nutr 1999; 69 (3): 381-387.
34. Must A, Phillips SM, Naumova EN, et al. Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember? Am J Epidemiol 2002; 155 (7): 672-679.
35. Musso G, Gambino R, Cassader M, Pagano G,. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43 (8): 617-649.